X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-01-25 | MRNA | Afeyan Noubar | Dir | S - Sale | $194.33 | -10,000 | 15,123,952 | 0% | -$1,943,300 | ||||||
| DM | 2023-01-25 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $191.39 | -80,000 | 21,027,198 | 0% | -$15,310,775 | |||||
2023-01-18 | MRNA | Afeyan Noubar | Dir | S - Sale | $200.20 | -10,000 | 15,133,952 | 0% | -$2,002,000 | ||||||
| DM | 2023-01-18 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $195.01 | -80,000 | 21,027,198 | 0% | -$15,600,773 | |||||
2023-01-11 | MRNA | Afeyan Noubar | Dir | S - Sale | $188.57 | -10,000 | 15,143,952 | 0% | -$1,885,700 | ||||||
| DM | 2023-01-11 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $185.26 | -80,000 | 21,027,198 | 0% | -$14,820,872 | |||||
2023-01-04 | MRNA | Afeyan Noubar | Dir | S - Sale | $182.15 | -10,000 | 15,153,952 | 0% | -$1,821,500 | ||||||
| DM | 2023-01-04 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $175.84 | -80,000 | 21,027,198 | 0% | -$14,067,534 | |||||
| DM | 2022-12-28 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $178.40 | -90,000 | 21,027,198 | 0% | -$16,055,833 | |||||
| D | 2022-12-28 | MRNA | Andres Juan | See remarks | S - Sale+OE | $180.00 | -2,000 | 12,803 | -14% | -$360,000 | |||||
2022-12-21 | MRNA | Afeyan Noubar | Dir | S - Sale | $201.70 | -10,000 | 15,163,952 | 0% | -$2,017,000 | ||||||
| DM | 2022-12-21 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $206.60 | -90,000 | 21,037,198 | 0% | -$18,594,122 | |||||
| D | 2022-12-21 | MRNA | Andres Juan | See remarks | S - Sale+OE | $201.70 | -2,000 | 12,803 | -14% | -$403,400 | |||||
2022-12-14 | MRNA | Afeyan Noubar | Dir | S - Sale | $195.00 | -10,000 | 15,173,952 | 0% | -$1,950,000 | ||||||
| DM | 2022-12-14 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $208.66 | -90,000 | 21,047,198 | 0% | -$18,779,797 | |||||
| D | 2022-12-14 | MRNA | Andres Juan | See remarks | S - Sale+OE | $195.00 | -2,000 | 12,803 | -14% | -$390,000 | |||||
2022-12-07 | MRNA | Afeyan Noubar | Dir | S - Sale | $172.16 | -10,000 | 15,183,952 | 0% | -$1,721,600 | ||||||
| D | 2022-12-07 | MRNA | Andres Juan | See remarks | S - Sale+OE | $172.16 | -2,000 | 12,803 | -14% | -$344,320 | |||||
| DM | 2022-12-07 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $180.32 | -90,000 | 21,057,198 | 0% | -$16,228,583 | |||||
| D | 2022-12-08 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $179.15 | -490 | 4,772 | -9% | -$87,783 | |||||
2022-11-30 | MRNA | Afeyan Noubar | Dir | S - Sale | $173.52 | -10,000 | 15,193,952 | 0% | -$1,735,200 | ||||||
| DM | 2022-11-30 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $176.28 | -90,000 | 21,067,198 | 0% | -$15,864,993 | |||||
| D | 2022-11-30 | MRNA | Andres Juan | See remarks | S - Sale+OE | $173.52 | -2,000 | 12,803 | -14% | -$347,040 | |||||
| D | 2022-11-29 | MRNA | Andres Juan | See remarks | S - Sale+OE | $173.80 | -814 | 12,803 | -6% | -$141,475 | |||||
| D | 2022-11-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $173.80 | -1,085 | 1,783,465 | 0% | -$188,576 | |||||
| D | 2022-11-25 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $175.84 | -50,000 | 21,077,198 | 0% | -$8,791,866 | |||||
2022-11-23 | MRNA | Afeyan Noubar | Dir | S - Sale | $178.01 | -10,000 | 15,203,952 | 0% | -$1,780,100 | ||||||
| D | 2022-11-23 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $176.20 | -40,000 | 21,087,198 | 0% | -$7,047,892 | |||||
| D | 2022-11-23 | MRNA | Andres Juan | See remarks | S - Sale+OE | $178.01 | -2,000 | 11,809 | -14% | -$356,020 | |||||
2022-11-16 | MRNA | Afeyan Noubar | Dir | S - Sale | $184.25 | -10,000 | 15,213,952 | 0% | -$1,842,500 | ||||||
| D | 2022-11-16 | MRNA | Andres Juan | See remarks | S - Sale+OE | $184.25 | -2,000 | 11,809 | -14% | -$368,500 | |||||
| DM | 2022-11-16 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $183.27 | -90,000 | 21,087,198 | 0% | -$16,494,504 | |||||
| DM | 2022-11-09 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $165.51 | -90,000 | 21,097,198 | 0% | -$14,896,262 | |||||
| D | 2022-11-10 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $165.59 | -231 | 1,782,140 | 0% | -$38,251 | |||||
| DM | 2022-11-09 | MRNA | Andres Juan | See remarks | S - Sale+OE | $162.77 | -2,192 | 11,809 | -16% | -$356,793 | |||||
2022-11-09 | MRNA | Afeyan Noubar | Dir | S - Sale | $162.50 | -10,000 | 15,223,952 | 0% | -$1,625,000 | ||||||
| D | 2022-11-07 | MRNA | Burton Paul | Chief Medical Officer | S - Sale+OE | $158.68 | -192 | 954 | -17% | -$30,467 | |||||
2022-11-02 | MRNA | Afeyan Noubar | Dir | S - Sale | $154.20 | -10,000 | 15,233,952 | 0% | -$1,542,000 | ||||||
| DM | 2022-11-02 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $148.70 | -90,000 | 21,107,198 | 0% | -$13,382,627 | |||||
| D | 2022-11-02 | MRNA | Andres Juan | See remarks | S - Sale+OE | $154.20 | -2,000 | 11,566 | -15% | -$308,400 | |||||
| D | 2022-10-28 | MRNA | Andres Juan | See remarks | S - Sale+OE | $150.00 | -4,000 | 11,566 | -26% | -$600,000 | |||||
2022-10-26 | MRNA | Afeyan Noubar | Dir | S - Sale | $137.25 | -10,000 | 15,243,952 | 0% | -$1,372,500 | ||||||
| DM | 2022-10-26 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $143.10 | -90,000 | 21,117,198 | 0% | -$12,878,891 | |||||
2022-10-19 | MRNA | Afeyan Noubar | Dir | S - Sale | $132.50 | -10,000 | 15,253,952 | 0% | -$1,325,000 | ||||||
| DM | 2022-10-19 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $123.05 | -90,000 | 21,127,198 | 0% | -$11,074,615 | |||||
2022-10-12 | MRNA | Afeyan Noubar | Dir | S - Sale | $135.36 | -10,000 | 15,263,952 | 0% | -$1,353,600 | ||||||
| DM | 2022-10-12 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $132.07 | -90,000 | 21,137,198 | 0% | -$11,886,324 | |||||
2022-10-05 | MRNA | Afeyan Noubar | Dir | S - Sale | $122.40 | -10,000 | 15,273,952 | 0% | -$1,224,000 | ||||||
| DM | 2022-10-05 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $124.51 | -90,000 | 21,147,198 | 0% | -$11,206,123 | |||||
2022-09-28 | MRNA | Afeyan Noubar | Dir | S - Sale | $123.58 | -10,000 | 15,283,952 | 0% | -$1,235,800 | ||||||
| DM | 2022-09-28 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $119.91 | -90,000 | 21,157,198 | 0% | -$10,791,568 | |||||
2022-09-21 | MRNA | Afeyan Noubar | Dir | S - Sale | $130.37 | -10,000 | 15,293,952 | 0% | -$1,303,700 | ||||||
| DM | 2022-09-21 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $126.61 | -90,000 | 21,167,198 | 0% | -$11,394,601 | |||||
2022-09-14 | MRNA | Afeyan Noubar | Dir | S - Sale | $134.00 | -10,000 | 15,303,952 | 0% | -$1,340,000 | ||||||
| DM | 2022-09-14 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $138.04 | -90,000 | 21,177,198 | 0% | -$12,423,601 | |||||
| DM | 2022-09-12 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $140.18 | -6,972 | 1,781,849 | 0% | -$977,320 | |||||
2022-09-07 | MRNA | Afeyan Noubar | Dir | S - Sale | $129.68 | -10,000 | 15,313,952 | 0% | -$1,296,800 | ||||||
| D | 2022-09-08 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $137.44 | -478 | 3,949 | -11% | -$65,698 | |||||
| DM | 2022-09-07 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $136.84 | -90,000 | 21,187,198 | 0% | -$12,315,938 | |||||
2022-08-31 | MRNA | Afeyan Noubar | Dir | S - Sale | $136.95 | -10,000 | 15,323,952 | 0% | -$1,369,500 | ||||||
| DM | 2022-08-31 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $133.43 | -90,000 | 21,197,198 | 0% | -$12,008,489 | |||||
| D | 2022-08-29 | MRNA | Andres Juan | See remarks | S - Sale+OE | $135.81 | -839 | 11,566 | -7% | -$113,947 | |||||
| D | 2022-08-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $135.81 | -1,119 | 1,781,849 | 0% | -$151,974 | |||||
| DM | 2022-08-24 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $141.35 | -90,000 | 21,207,198 | 0% | -$12,721,780 | |||||
| DM | 2022-08-23 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $142.25 | -10,000 | 1,780,558 | -1% | -$1,422,500 | |||||
2022-08-17 | MRNA | Afeyan Noubar | Dir | S - Sale | $165.24 | -10,000 | 15,333,952 | 0% | -$1,652,400 | ||||||
| D | 2022-08-17 | MRNA | Andres Juan | See remarks | S - Sale+OE | $165.24 | -2,000 | 10,598 | -16% | -$330,480 | |||||
| DM | 2022-08-17 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $155.21 | -90,000 | 21,217,198 | 0% | -$13,968,573 | |||||
| DM | 2022-08-12 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $172.77 | -10,000 | 1,780,558 | -1% | -$1,727,650 | |||||
2022-08-10 | MRNA | Afeyan Noubar | Dir | S - Sale | $174.09 | -10,000 | 15,343,952 | 0% | -$1,740,900 | ||||||
| DM | 2022-08-10 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $173.43 | -90,000 | 21,227,198 | 0% | -$15,608,827 | |||||
| D | 2022-08-10 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $173.66 | -244 | 1,780,558 | 0% | -$42,374 | |||||
| D | 2022-08-10 | MRNA | Andres Juan | See remarks | S - Sale+OE | $174.05 | -2,204 | 10,598 | -17% | -$383,607 | |||||
| D | 2022-08-10 | MRNA | Meline David W | CFO | S - Sale+OE | $173.66 | -164 | 2,857 | -5% | -$28,481 | |||||
2022-08-03 | MRNA | Afeyan Noubar | Dir | S - Sale | $167.99 | -10,000 | 15,353,952 | 0% | -$1,679,900 | ||||||
| DM | 2022-08-03 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $189.41 | -90,000 | 21,237,198 | 0% | -$17,046,777 | |||||
| D | 2022-08-03 | MRNA | Andres Juan | See remarks | S - Sale+OE | $167.99 | -2,000 | 10,367 | -16% | -$335,980 | |||||
2022-07-27 | MRNA | Afeyan Noubar | Dir | S - Sale | $161.00 | -10,000 | 15,363,952 | 0% | -$1,610,000 | ||||||
| D | 2022-07-27 | MRNA | Andres Juan | See remarks | S - Sale+OE | $161.00 | -2,000 | 10,367 | -16% | -$322,000 | |||||
| DM | 2022-07-27 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $156.58 | -90,000 | 21,247,198 | 0% | -$14,092,039 | |||||
| D | 2022-07-25 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $162.75 | -10,000 | 1,780,280 | -1% | -$1,627,500 | |||||
2022-07-20 | MRNA | Afeyan Noubar | Dir | S - Sale | $167.00 | -10,000 | 15,373,952 | 0% | -$1,670,000 | ||||||
| DM | 2022-07-20 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $167.28 | -90,000 | 21,257,198 | 0% | -$15,054,723 | |||||
| D | 2022-07-20 | MRNA | Andres Juan | See remarks | S - Sale+OE | $167.00 | -2,000 | 10,367 | -16% | -$334,000 | |||||
2022-07-13 | MRNA | Afeyan Noubar | Dir | S - Sale | $168.88 | -10,000 | 15,383,952 | 0% | -$1,688,800 | ||||||
2022-07-13 | MRNA | Afeyan Noubar | Dir | S - Sale | $168.88 | -10,000 | 15,383,952 | 0% | -$1,688,800 | ||||||
| DM | 2022-07-13 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $166.93 | -90,000 | 21,267,198 | 0% | -$15,023,482 | |||||
| D | 2022-07-13 | MRNA | Andres Juan | See remarks | S - Sale+OE | $168.88 | -2,000 | 10,367 | -16% | -$337,760 | |||||
| DM | 2022-07-12 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $171.81 | -10,000 | 1,780,280 | -1% | -$1,718,050 | |||||
2022-07-06 | MRNA | Afeyan Noubar | Dir | S - Sale | $154.85 | -10,000 | 15,393,952 | 0% | -$1,548,500 | ||||||
| DM | 2022-07-06 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $163.57 | -90,000 | 21,277,198 | 0% | -$14,721,360 | |||||
| D | 2022-07-06 | MRNA | Andres Juan | See remarks | S - Sale+OE | $154.85 | -2,000 | 10,367 | -16% | -$309,700 | |||||
| D | 2022-07-01 | MRNA | Andres Juan | See remarks | S - Sale+OE | $150.00 | -6,000 | 10,367 | -37% | -$900,000 | |||||
2022-06-29 | MRNA | Afeyan Noubar | Dir | S - Sale | $140.47 | -10,000 | 15,403,952 | 0% | -$1,404,700 | ||||||
| DM | 2022-06-29 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $142.90 | -90,000 | 21,287,198 | 0% | -$12,861,345 | |||||
| DM | 2022-06-23 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $139.97 | -10,000 | 1,780,280 | -1% | -$1,399,700 | |||||
2022-06-22 | MRNA | Afeyan Noubar | Dir | S - Sale | $127.69 | -10,000 | 15,413,952 | 0% | -$1,276,900 | ||||||
| DM | 2022-06-22 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $138.39 | -90,000 | 21,297,198 | 0% | -$12,454,880 | |||||
| DM | 2022-06-15 | MRNA | Bancel Stephane | CEO | S - Sale+OE | $124.04 | -90,000 | 21,307,198 | 0% | -$11,163,130 | |||||
| D | 2022-06-13 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $123.00 | -10,000 | 1,780,280 | -1% | -$1,230,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |